Omeros Corporation

Omeros Corporationverified

OMER

Price:

$11.03

Market Cap:

$781.96M

Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical programs include Narsoplimab (OMS721/MASP-2) that has completed pivotal studies for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (HSCT-TMA); that is in Phase III clinical trial for immunoglobulin A nephropathy (IgAN) and atypical hemolytic uremic syndrome (aHUS); and Phase II clinical trial to treat COVID-19. Its clinical programs...[Read more]

Industry

Biotechnology

IPO Date

2009-10-08

Stock Exchange

NASDAQ

Ticker

OMER

The Current Ratio as of December 2025 (TTM) for Omeros Corporation (OMER) is 0.89

According to Omeros Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 0.89. This represents a change of -21.76% compared to the average of 1.14 of the last 4 quarters.

Omeros Corporation (OMER) Historical Current Ratio (quarterly & annually)

How has OMER Current Ratio performed in the past?

The mean historical Current Ratio of Omeros Corporation over the last ten years is 3.24. The current 0.89 Current Ratio has changed 2.65% with respect to the historical average. Over the past ten years (40 quarters), OMER's Current Ratio was at its highest in in the September 2022 quarter at 7.30. The Current Ratio was at its lowest in in the June 2025 quarter at 0.81.

Quarterly (TTM)
Annual

Average

3.24

Median

3.50

Minimum

1.69

Maximum

4.79

Omeros Corporation (OMER) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Omeros Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 360.02%

Maximum Annual Current Ratio = 4.79

Minimum Annual Increase = -58.73%

Minimum Annual Current Ratio = 1.69

Quarterly (TTM)
Annual
YearCurrent RatioChange
20241.69-58.73%
20234.0925.75%
20223.25-32.10%
20214.7916.23%
20204.12120.15%
20191.87-22.24%
20182.41-41.60%
20174.129.86%
20163.7564.07%
20152.29360.02%

Omeros Corporation (OMER) Average Current Ratio

How has OMER Current Ratio performed in the past?

The current Current Ratio of Omeros Corporation (OMER) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

3.01

5-year avg

3.59

10-year avg

3.24

Omeros Corporation (OMER) Current Ratio vs. Peers

How is OMER’s Current Ratio compared to its peers?

Omeros Corporation’s Current Ratio is less than ADC Therapeutics S.A. (4.93), less than Neumora Therapeutics, Inc. Common Stock (6.85), less than Lexicon Pharmaceuticals, Inc. (4.16), less than RAPT Therapeutics, Inc. (12.04), less than Bicycle Therapeutics plc (10.66), less than 4D Molecular Therapeutics, Inc. (8.42), less than KalVista Pharmaceuticals, Inc. (5.37), less than Fulcrum Therapeutics, Inc. (17.70), less than Gossamer Bio, Inc. (4.40), less than Ocugen, Inc. (1.83),

Build a custom stock screener for Omeros Corporation (OMER) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Omeros Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Omeros Corporation (OMER) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Omeros Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Omeros Corporation's Current Ratio?

How is the Current Ratio calculated for Omeros Corporation (OMER)?

What is the highest Current Ratio for Omeros Corporation (OMER)?

What is the 3-year average Current Ratio for Omeros Corporation (OMER)?

What is the 5-year average Current Ratio for Omeros Corporation (OMER)?

How does the current Current Ratio for Omeros Corporation (OMER) compare to its historical average?